Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1569)	11/3/1998 6:30:00 PM
From: Zvi Yammer	Read Replies (2) \| Respond to of 2742

PINE BROOK, N.J., Nov. 3 /PRNewswire/ -- Pasteur Merieux Connaught, a subsidiary of Rhone-Poulenc Group (NYSE: RP - news), and Cistron Biotechnology, Inc. (OTC: CIST - news) announced today that on October 30, 1998, Pasteur Merieux Connaught purchased 1,333,333 shares of Cistron common stock and received warrants to purchase 666,667 additional shares at $.25 per share, for an aggregate price of $1,000,000. My spin on the text is that the aggreagate of the 1.333 and the .667 million shares will be a cash payment of 1mil dollars. This comes out to an avg. price of 50 cents per share. The million includes the money to be paid in the future for 666,667 shares @ .25